We have investigated whether metabolic syndrome is a risk factor for carotid atherosclerosis also in normotensive or prehypertensive individuals. Methods: We analyzed the data from 851 subjects who had a blood pressure of less than 140/90 mmHg and were not taking antihypertensive medication. Metabolic syndrome was defined according to three different criteria: Japan criteria (Japan-MetS); those of the National Cholesterol Education Program (NCEP)-Adult Treatment Panel (ATP ) (NCEP-MetS); and modified NCEP-ATP criteria in which body mass index was used as a surrogate for waist circumference (modified NCEPMetS). Results: Japan-MetS, NCEP-MetS, and modified NCEP-MetS were found, respectively, in 1%, 4%, and 4%, of women, and in 10%, 5%, and 9%, of men. After the adjustment for gender and age, the association between MetS and carotid atherosclerosis did not reach statistical significance. Conclusion: Although the number of enrolled subjects was relatively small, these data may further support the importance of controlling blood pressure within the optimal range for the purpose of preventing atherosclerosis in individuals with metabolic syndrome. 
Introduction
Metabolic syndrome (MetS), which is thought to be linked with insulin resistance, is a risk factor for cardiovascular disease 1) and stroke 2) . We have previously shown that MetS is a risk factor for carotid atherosclerosis in those undergoing general health screening 3) . Several other studies have shown an association between atherosclerotic diseases and MetS in individuals of different race and ethnicity, although these studies may have used different, or slightly modified, diagnostic criteria for MetS, such as those proposed by the World Health Organization (WHO) 4) , the National Cholesterol Education Program (NCEP) 5) , or those used in our country 6) . Although these criteria vary in some components, they all share several conventional atherogenic risk factors as diagnostic criteria [7] [8] [9] , including impaired glucose metabolism, hypertension, and dyslipidemia.
Individuals with prominent hemodynamic and metabolic abnormalities can readily be recognized and managed by health care providers. Thus, it might be questioned whether, by using the concept of MetS, we can identify individuals at higher risk for atherosclerotic complications among those with only mild hemodynamic and/or metabolic abnormalities. We found that hypertension is the most common component of metabolic syndrome and the greatest contributor to carotid arteriosclerosis in individuals who had undergone general health screening 10) . Recently, we investigated data from subjects with normotension or prehypertension, who underwent general health screening between September 1994 and December 2003, and found that MetS might not be an independent risk factor for carotid atherosclerosis in such a population 11) . As waist circum-ference (WC) data were not available in that study, however, body mass index (BMI) was used as a surrogate for waist circumference for the diagnosis of MetS. As WC has recently become a routine measurement during general health screening at our institute, here we re-analyzed whether MetS, as diagnosed by Japan and NCEP criteria, is a risk factor for carotid atherosclerosis in normotensive or prehypertensive individuals.
Methods

Study Subjects
The study was approved by The Ethical Committee of Mitsui Memorial Hospital. Between October 2005 and June 2006, 1323 subjects underwent general health screening including carotid ultrasonography, measurement of other metabolic markers, and waist circumference necessary to assess the presence or absence of MetS at the Center for Multiphasic Health Testing and Services, Mitsui Memorial Hospital. Among them 851 (342 women, 509 men), who were not taking anti-hypertensive medications, were found to have a systolic blood pressure (SBP) of less than 140 mmHg and a diastolic blood pressure (DBP) of less than 90 mmHg, and were enrolled in the current study. Data on basal insulin levels were available for all subjects enrolled, and the homeostasis model assessment of insulin resistance (HOMA-IR) was calculated in these individuals according to the following formula: HOMA-IR fasting immunoreactive insulin ( U/mL) fasting plasma glucose (FPG, mg/dL))/405 12) . Normotension or prehypertension was defined according to the criteria of JNC 7 13) , unless otherwise stated.
Definition of Metabolic Syndrome
For the diagnosis of MetS, we used three different criteria.
(1) Definition and diagnostic criteria of MetS in Japan 6) (Japan-MetS Of the 851 study subjects, 11 (1%) were taking anti-diabetic medicine, and were considered to fulfill the FPG criterion.
Carotid Ultrasonography
Carotid artery status was assessed using a highresolution B-mode ultrasonography instrument (Sonolayer SSA270A, Toshiba, Japan) equipped with a 7.5 MHz transducer (PLF-703ST, Toshiba). In the current study, we diagnosed carotid plaque according to the criteria of the Society for the Study of Early Atherosclerosis; these criteria differ from those used in several previous studies 3) , where carotid plaque was defined as clearly isolated focal thickening of the intima-media layer with a thickness of 1.3 mm. Here, we defined carotid plaque by a portion of the artery with an intima-media complex thickness of 1.1 mm 14) with a focal protrusion or point(s) of inflexion. The difference in the prevalence of carotid plaque in health screening participants between the current and previous studies 3) may be due to the difference in criteria used to diagnose carotid plaque. On the other hand, carotid wall intima-media thickening was said to be present when intima-media thickness, measured at the far wall of the distal 10 mm of the common carotid artery, was 1.0 mm 3)
.
Statistical Analysis
The data in this study were analyzed by the 2 test, unpaired t test, and multivariate logistic regression analysis using computer software, StatView ver. 5.0. A value of p 0.05 was taken as significant. The results are expressed as the mean SD.
Results
Prevalence of MetS Defined by Three Diagnostic Criteria
The age of the subjects ranged from 25 to 91 years (women, 25-91 years; men, 29-89 years) ( Table 1) . Japan-MetS, NCEP-MetS, and modified NCEP-MetS were found, respectively, in 4 (1%), 14 (4%), and 13 (4%) women, and in 49 (10%), 24 (5%), and 47 (9%) men. The prevalence and overlap of MetS defined by these criteria are shown in Fig. 1 . In the study population, 767 (90.1%) individuals were found to be free from MetS, as defined by any of the three criteria. HOMA-IR in individuals with or without Japan-MetS was, respectively, 4.0 2.5 or 1.2 0.7 (p 0.0001) in women, and 2.4 1.5 or 1.5 0.9, respectively, (p 0.0001) in men. HOMA-IR in individuals with or without NCEP-MetS was, respectively, 2.7 1.6 or 1.2 0.7 (p 0.0001) in women, and 2.8 1.6 or 1.67 1.06 (p 0.0001) in men. HOMA-IR in individuals with or without modified NCEP-MetS was, respectively, 2.7 1.7 and 1.2 0.7 (p 0.0001) in women, and 2.6 1.6 and 1.5 0.90 (p 0.0001) in men. The characteristics and laboratory data of individuals who had metabolic syndrome defined by either criterion are described in Table 2 .
In the whole study population, 674 individuals (284 women, 390 men) had a BP of 130/85 mmHg, and in this subpopulation, the prevalence of JapanMetS, NCEP-MetS, and modified NCEP-MetS was found to be, respectively, 0 (0%), 5 (2%), and 4 (1%) in women, and 9 (2%), 7 (2%), and 14 (4%) in men. In addition, in 456 normotensive individuals (219 women, 237 men) (i.e., individuals with a BP of 120/ 80 mmHg), the prevalence of Japan-MetS, NCEPMetS, and modified NCEP-MetS was found to be, respectively, 0 (0%), 5 (2%), and 4 (2%), respectively, in women, and 5 (2%), 3 (1%), and 4 (2%), respectively, in men.
Relation between Carotid Plaque and MetS
Carotid plaque was found in 145 (42%) of the After adjustment for gender and age, logistic regression analysis showed that the association between MetS defined by the three different criteria and carotid plaque did not reach statistical significance. After further adjustment for smoking status and SBP, the odds ratio for carotid plaque was decreased and, again, MetS as defined by any of the three criteria was not found to be associated with carotid plaque (Table 3) .
Relation between Carotid Intima-Media Thickening and MetS
Carotid intima-media thickening was found in 20/342 (5.8%) women and 61/509 (12.0%) men. After adjustment for gender and age, logistic regression analysis showed that the odds ratio of MetS defined by the three different criteria for carotid intima-media thickening was as follows: Japan-MetS, 1.63 (95% CI 0.69-3.84. p 0.27); NCEP-MetS, 1.25 (95% CI 0.42-3.78, p 0.69); and modified NCEP-MetS, 0.94 (95% CI 0.35-2.58, p 0.92). After further adjustment for smoking status and SBP, the odds ratio for carotid plaque was decreased and, again, MetS as defined by any of the three criteria was not found to be associated 
Discussion
In the present study, we found that, in individuals with normotension or prehypertension, the prevalence of Japan-MetS, NCEP-MetS, and modified NCEPMetS was, respectively, 1%, 4%, and 4% in women, and 10%, 5% and 9% in men. MetS defined by JapanMetS, NCEP-MetS, or modified NCEP-MetS was not found to be statistically significantly associated with carotid plaque after adjustment for age and gender. This statistical non-significance remained after further adjustment for smoking status and systolic blood pressure.
In a previous report, we showed that MetS was associated with carotid plaque, which was independent of other conventional atherogenic risk factors 3) . On the other hand, we found that MetS may not be a risk factor for carotid atherosclerosis in individuals with normotension or prehypertension 11) . In those previous studies, for the diagnosis of MetS, we used NCEP-ATP criteria with BMI as a surrogate for WC, designated here as modified NCEP-MetS. In the current study, we extended the concept that there is no association between MetS and carotid atherosclerosis even when using other diagnostic criteria including the WC component. Although the results obtained are in agreement with those of a previous report 11) , several points need careful consideration.
First, the number of subjects enrolled was not large in the current study, which may weaken the statistical power. For example, although not statistically significant, the odds ratio of Japan-MetS for carotid plaque after adjustment for sex and age (1.62) was almost comparable to the odds ratio (1.72) of modified NCEPMetS for carotid plaque after adjusting for sex, age, total cholesterol levels, and smoking status found previously in health screening participants 15) . Thus, we should re-evaluate these observations in future studies after increasing the number of subjects enrolled. We should also investigate whether the association between MetS, as defined by the Japan criteria or by the NCEP-ATP criteria, and carotid atherosclerosis remains statistically significant after further adjustment for other traditional cardiovascular risk factors and/or each component of MetS.
Second, in the current study, we used a different definition of carotid plaque from that used in our previous study, where carotid plaque was defined as clearly isolated focal thickening of the intima-media layer with a thickness of 1.3 mm at the common or internal carotid artery or the carotid bulb 11) . In the current study, by contrast, carotid plaque was diagnosed when maximal intima-media thickness was 1.1 mm. It may be expected that the prevalence of carotid atherosclerosis would substantially differ according to the criteria used: in individuals with normotension or prehypertension, carotid plaque was found in 42% of women (mean age 56 years) and 58% of men (mean age 57 years) in the current study, and in 13% of women (mean age 55 years) and 24% of men (mean age 55 years) in the previous study 11) . In the current study, the prevalence of Japan-MetS in men was more than 8-fold that in women. This marked difference is in agreement with a recent study reported by another group, in which the prevalence of Japan-MetS in the general Japanese population was found to be 1.7% (mean age 46 1 years) in women and 12.1% (mean age 46 0 years) in men 16) . We have found that in studies using NCEP criteria, the prevalence of MetS (NCEP-MetS) is much closer between genders, which may also be in agreement with studies analyzing the Japanese population [16] [17] [18] [19] . When comparing the prevalence of MetS reported in various studies, however, it should be noted that diagnostic criteria with certain minor modifications may have been used in various studies.
We have previously reported that hypertension is the most frequent component of modified NCEPMetS and the greatest contributor to carotid atherosclerosis among its risk factor components 10) . Mancia et al. reported in a population-based study in San Marino that the prevalence of MetS was 24% in hypertensive subjects, whereas it was as little as 4% in subjects with optimal, normal, or high-normal BP 20) . Similarly, during the current study period, we found that the prevalence of Japan-MetS in the whole study population who had undergone carotid ultrasonography was 3% in women and 22% in men (Ishizaka Y, unpublished data); in addition, in the current study, which targeted individuals with optimal, normal, or high normal BP, it was 1% in women and 10% in men. Furthermore, when individuals with a BP 130/85 mmHg were removed from our analysis (corresponding to optimal or normal BP according to JNC classification 21) ), the prevalence of Japan-MetS was 0% in women and 2% in men. Kanauchi et al. analyzed the prevalence of MetS, as diagnosed by NCEP-MetS with a modified WC criterion, in individuals who were not taking anti-hypertensive medication, and found it to be 10%, 19%, and 36% in those with normotension, prehypertension, and hypertension, respectively 22) . These data collectively indicate that the prevalence of MetS, regardless of the diagnostic criteria used, is substantially lower in individuals whose BP is in the preferable range.
In summary, we analyzed individuals who underwent general health screening including carotid ultrasonography, and found that Japan-MetS, NCEP-MetS, or modified NCEP-MetS was not a predictor for carotid atherosclerosis in normotensive or prehypertensive individuals after adjusting for sex and age. Our data suggest that maintaining BP within the optimal range is crucial for reducing the risk for both metabolic syndrome and carotid atherosclerosis. As our study involved a relatively small study population, further investigation should be performed after increasing the size of the study population in the future.
